These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 11321154

  • 1. Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration.
    Lincoff H, Kreissig I.
    Retina; 2001; 21(2):191. PubMed ID: 11321154
    [No Abstract] [Full Text] [Related]

  • 2. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas.
    Hesse L, Schmidt J, Kroll P.
    Graefes Arch Clin Exp Ophthalmol; 1999 Apr; 237(4):273-7. PubMed ID: 10208258
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration.
    Krepler K, Kruger A, Tittl M, Stur M, Wedrich A.
    Retina; 2000 Apr; 20(3):251-6. PubMed ID: 10872929
    [Abstract] [Full Text] [Related]

  • 4. Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage.
    Hesse L, Schroeder B, Heller G, Kroll P.
    Retina; 2000 Apr; 20(5):500-5. PubMed ID: 11039425
    [Abstract] [Full Text] [Related]

  • 5. tPA and gas in submacular hemorrhage.
    Lewis H.
    Ophthalmology; 2002 May; 109(5):824; author reply 825. PubMed ID: 11986071
    [No Abstract] [Full Text] [Related]

  • 6. Subretinal tissue plasminogen activator injection to treat submacular haemorrhage during age-related macular degeneration.
    Dewilde E, Delaere L, Vaninbroukx I, Van Calster J, Stalmans P.
    Acta Ophthalmol; 2014 Sep; 92(6):e497-8. PubMed ID: 24943231
    [No Abstract] [Full Text] [Related]

  • 7. A new technique for the subretinal injection of small volumes by using a modified viscous fluid injector system.
    Kayikcioglu OR, Mendez T, Morrison V, Freeman WR.
    Retina; 2006 Sep; 26(9):1089-90. PubMed ID: 16622393
    [No Abstract] [Full Text] [Related]

  • 8. Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD.
    Hay SR, Madonna RJ.
    Optometry; 2000 Nov; 71(11):715-21. PubMed ID: 11101129
    [Abstract] [Full Text] [Related]

  • 9. [The intravitreal application of the tissue plasminogen activator in the treatment of submacular hemorrhage--a case report].
    Fric E, Sín M, Rehák M, Chrapek O, Simicák J, Fehák J.
    Cesk Slov Oftalmol; 2008 Nov; 64(6):237-40. PubMed ID: 19110965
    [Abstract] [Full Text] [Related]

  • 10. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
    Hassan AS, Johnson MW, Schneiderman TE, Regillo CD, Tornambe PE, Poliner LS, Blodi BA, Elner SG.
    Ophthalmology; 1999 Oct; 106(10):1900-6; discussion 1906-7. PubMed ID: 10519583
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
    Kung YH, Wu TT, Hong MC, Sheu SJ.
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):469-74. PubMed ID: 20925578
    [Abstract] [Full Text] [Related]

  • 12. TISSUE PLASMINOGEN ACTIVATOR FOR SUBFOVEAL HEMORRHAGE DUE TO AGE-RELATED MACULAR DEGENERATION: Comparison of 3 Treatment Modalities.
    Fassbender JM, Sherman MP, Barr CC, Schaal S.
    Retina; 2016 Oct; 36(10):1860-5. PubMed ID: 26945238
    [Abstract] [Full Text] [Related]

  • 13. Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration.
    Fang IM, Lin YC, Yang CH, Yang CM, Chen MS.
    Eye (Lond); 2009 Feb; 23(2):397-406. PubMed ID: 17975562
    [Abstract] [Full Text] [Related]

  • 14. Pneumatic displacement of submacular hemorrhage.
    Hesse L, Kroll P.
    Ophthalmology; 2000 Dec; 107(12):2119-20. PubMed ID: 11097565
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of submacular hemorrhage with tissue plasminogen activator and pneumatic displacement in age-related macular degeneration.
    Sniatecki JJ, Ho-Yen G, Clarke B, Barbara R, Lash S, Papathomas T, Antonakis S, Gupta B.
    Eur J Ophthalmol; 2021 Mar; 31(2):643-648. PubMed ID: 31813290
    [Abstract] [Full Text] [Related]

  • 16. Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome.
    Schulze SD, Hesse L.
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):717-20. PubMed ID: 12271367
    [Abstract] [Full Text] [Related]

  • 17. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement.
    Handwerger BA, Blodi BA, Chandra SR, Olsen TW, Stevens TS.
    Arch Ophthalmol; 2001 Jan; 119(1):28-32. PubMed ID: 11146723
    [Abstract] [Full Text] [Related]

  • 18. [Subretinal hematoma in age-related macular degeneration: treatment with intravitreal injection of tPA and gas].
    Leguay J, Gastaud P.
    J Fr Ophtalmol; 2000 Oct; 23(8):797-801. PubMed ID: 11033502
    [Abstract] [Full Text] [Related]

  • 19. Management of submacular haemorrhage in age-related macular degeneration with intravitreal tenecteplase.
    McAllister IL, Chen SD, Patel JI, Fleming BL, Yu DY.
    Br J Ophthalmol; 2010 Feb; 94(2):260-1. PubMed ID: 20139293
    [No Abstract] [Full Text] [Related]

  • 20. Intravitreal tissue plasminogen activator, perfluoropropane (C3F8), and ranibizumab or photodynamic therapy for submacular hemorrhage secondary to wet age-related macular degeneration.
    Papavasileiou E, Steel DH, Liazos E, McHugh D, Jackson TL.
    Retina; 2013 Apr; 33(4):846-53. PubMed ID: 23400079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.